Avio Smart Market Stack Invests ₹7.5 Crore in Huwel Lifesciences

Jyoti Rathi - Kolkata Bureau Jul 15, 2026 450 Views

Avio Smart Market Stack (formerly Bartronics India) has invested an additional ₹7.5 crore in Huwel Lifesciences to scale molecular diagnostic solutions. The partnership focuses on deploying point-of-care RT-PCR platforms and TB detection kits to underserved regions, aiming to bridge healthcare access gaps while driving long-term growth through its rural digital network.

Avio Smart Market Stack Limited (ASMS) has strengthened its health-tech division by making an additional investment of ₹7.5 crore in Hyderabad-based Huwel Lifesciences Private Limited. This strategic move is designed to accelerate the development and deployment of molecular diagnostic solutions, reinforcing the partnership between the two companies to enhance access to affordable, point-of-care testing across India and emerging global markets.

Deepening the Health-Tech Partnership

The investment is part of a broader collaboration between ASMS—formerly known as Bartronics India Limited—and Huwel Lifesciences, aimed at scaling diagnostic infrastructure. Huwel Lifesciences, led by Dr. Rachana Tripathi, operates an ISO-certified, CE/FDA-compliant facility and has established a robust portfolio of over 100 validated diagnostic products, including solutions for tuberculosis (TB), infectious diseases, and antimicrobial resistance.

Key components of this partnership include:

Decentralized Diagnostics: The upcoming launch of "Cubo," an ultra-compact RT-PCR platform designed for point-of-care testing in remote clinics, rural hospitals, and underserved regions.
Tuberculosis Eradication: Scaling the distribution of the Quantiplus® TB Fast Detection Kit, an affordable, ICMR-approved RT-PCR solution that supports the Government of India’s National TB Elimination Programme.
Research & Clinical Collaboration: Ongoing strategic engagement with premier institutions, such as the Mediciti Institute of Medical Sciences, to validate technologies and accelerate the real-world adoption of molecular diagnostic tools.

Strategic Rationale

For ASMS, this investment is a cornerstone of its "unified rural operating system" strategy, which integrates financial inclusion, agritech, and health-tech to empower underserved communities. By leveraging ASMS’s extensive network of over 5,000 villages and 40 million farmers, the company intends to bridge the gap in healthcare access by bringing sophisticated molecular diagnostics directly to the last mile.

"Healthcare access should not be determined by geography," stated Vidhya Sagar Reddy, Managing Director of Avio Smart Market Stack Limited. "This partnership not only supports critical national health missions like TB elimination but also creates a robust, recurring revenue model for our business."

Market Impact

The collaboration targets not only the Indian domestic market—aligned with national missions like 'TB Mukt Bharat' and Ayushman Bharat—but also expanding healthcare needs in Southeast Asia and Africa. By combining ASMS’s expertise in technology integration, government relations, and digital platforms with Huwel’s manufacturing and R&D capabilities, the partnership seeks to establish a diagnostic portfolio capable of serving diverse, high-growth markets.

Sources

Avio Smart Market Stack Limited - Official Company Profile & Investor Relations
ScanX News - Financial Disclosures and Investment Updates
Digital Health News - Industry Collaboration Reports
National Stock Exchange (NSE) Corporate Filings